Exercise, skeletal muscle and inflammation: ARE-binding proteins as key regulators in inflammatory and adaptive networks

Exercise Immunology Review

Volumn 21, Issue , 2015, Pages 42-57

  Beiter, Thomas ^a   Hoene, Miriam ^b   Prenzler, Frauke ^a   Mooren, Frank C ^c   Steinacker, Jürgen M ^d   Weigert, Cora ^b,e   Nieß, Andreas M ^a   Munz, Barbara ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

Au rich element binding protein (ABP); Cachexia; Exercise; HuR; Inflammation; mRNA stability; Regeneration; Resolution of inflammation; Skeletal muscle; ZFP36 TTP

Indexed keywords

CUG BINDING PROTEIN 1; ELAV LIKE PROTEIN 1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; KH TYPE SPLICING REGULATORY PROTEIN; MESSENGER RNA; REGULATOR PROTEIN; TRISTETRAPROLIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; AUTACOID; CYTOKINE; MUSCLE PROTEIN; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; ADAPTATION; AU RICH ELEMENT; BINDING SITE; CYTOKINE PRODUCTION; EXERCISE; GENE TARGETING; GENETIC STABILITY; HUMAN; INFLAMMATION; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REVIEW; SKELETAL MUSCLE; ANIMAL; ANIMAL EXPERIMENT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; RNA PROCESSING; RNA STABILITY;

3' UNTRANSLATED REGIONS; ADAPTATION, PHYSIOLOGICAL; ANIMALS; CYTOKINES; EXERCISE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; REGENERATION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84928698071     PISSN: 10775552     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (158)

1. Abdelmohsen K, Kuwano Y, Kim HH and Gorospe M. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem 389:243-255, 2008.
2. Abdelmohsen K, Srikantan S, Kuwano Y and Gorospe M. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc Natl Acad Sci U S A 105:20297-20302, 2008.
3. Akhmedov D and Berdeaux R. The effects of obesity on skeletal muscle regeneration. Front Physiol 4:371, 2013.
4. Al-Ahmadi W, Al-Ghamdi M, Al-Souhibani N and Khabar KS. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. J Pathol 230:28-38, 2013.
5. Amirouche A, Tadesse H, Lunde JA, Belanger G, Cote J and Jasmin BJ. Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics. Hum Mol Genet 22:3093-3111, 2013.
6. Amirouche A, Tadesse H, Miura P, Belanger G, Lunde JA, Cote J and Jasmin BJ. Converging pathways involving microRNA-206 and the RNA-binding protein KSRP control post-transcriptionally utrophin A expression in skeletal muscle. Nucleic Acids Res 42:3982-3997, 2014.
7. Apponi LH, Corbett AH and Pavlath GK. RNA-binding proteins and gene regulation in myogenesis. Trends Pharmacol Sci 32:652-658, 2011.
8. Argiles JM, Busquets S, Felipe A and Lopez-Soriano FJ. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol 37:1084-1104, 2005.
9. Argiles JM, Lopez-Soriano J, Almendro V, Busquets S and Lopez-Soriano FJ. Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Med Res Rev 25:49-65, 2005.
10. Arnold L, Henry A, Poron F, Baba-Amer Y, van RN, Plonquet A, Gherardi RK and Chazaud B. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204:1057-1069, 2007.
11. Arthur JS and Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13:679-692, 2013.
12. Ataie-Kachoie P, Pourgholami MH and Morris DL. Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer. Cytokine Growth Factor Rev 24:163-173, 2013.
13. Aurora AB and Olson EN. Immune modulation of stem cells and regeneration. Cell Stem Cell 15:14-25, 2014.
14. Bakheet T, Frevel M, Williams BR, Greer W and Khabar KS. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29:246-254, 2001.
15. Baou M, Jewell A and Murphy JJ. TIS11 family proteins and their roles in posttranscriptional gene regulation. J Biomed Biotechnol 2009:634520, 2009.
16. Beauchamp P, Nassif C, Hillock S, van der GK, von RC, Jasmin BJ and Gallouzi IE. The cleavage of HuR interferes with its transportin-2-mediated nuclear import and promotes muscle fiber formation. Cell Death Differ 17:1588-1599, 2010.
17. Beiter T, Fragasso A, Hudemann J, Niess AM and Simon P. Short-term treadmill running as a model for studying cell-free DNA kinetics in vivo. Clin Chem 57:633-636, 2011.
18. Beiter T, Fragasso A, Hudemann J, Schild M, Steinacker J, Mooren FC and Niess AM. Neutrophils release extracellular DNA traps in response to exercise. J Appl Physiol (1985) 117:325-333, 2014.
19. Bell SE, Sanchez MJ, Spasic-Boskovic O, Santalucia T, Gambardella L, Burton GJ, Murphy JJ, Norton JD, Clark AR and Turner M. The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev Dyn 235:3144-3155, 2006.
20. Blackshear PJ, Phillips RS, Ghosh S, Ramos SB, Richfield EK and Lai WS. Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins. Biol Reprod 73:297-307, 2005.
21. Brandt C, Jakobsen AH, Adser H, Olesen J, Iversen N, Kristensen JM, Hojman P, Wojtaszewski JF, Hidalgo J and Pilegaard H. IL-6 regulates exercise and training-induced adaptations in subcutaneous adipose tissue in mice. Acta Physiol (Oxf) 205:224-235, 2012.
22. Braun T and Gautel M. Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol 12:349-361, 2011.
23. Braun TP and Marks DL. Pathophysiology and treatment of inflammatory anorexia in chronic disease. J Cachexia Sarcopenia Muscle 1:135-145, 2010.
24. Briata P, Chen CY, Ramos A and Gherzi R. Functional and molecular insights into KSRP function in mRNA decay. Biochim Biophys Acta 1829:689-694, 2013.
25. Briata P, Forcales SV, Ponassi M, Corte G, Chen CY, Karin M, Puri PL and Gherzi R. p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell 20:891-903, 2005.
26. Briata P, Lin WJ, Giovarelli M, Pasero M, Chou CF, Trabucchi M, Rosenfeld MG, Chen CY and Gherzi R. PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis. Cell Death Differ 19:478-487, 2012.
27. Brooks SA, Connolly JE and Rigby WF. The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway. J Immunol 172:7263-7271, 2004.
28. Buckley CD, Gilroy DW, Serhan CN, Stockinger B and Tak PP. The resolution of inflammation. Nat Rev Immunol 13:59-66, 2013.
29. Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, Sefik E, Tan TG, Wagers AJ, Benoist C and Mathis D. A special population of regulatory T cells potentiates muscle repair. Cell 155:1282-1295, 2013.
30. Busse M, Schwarzburger M, Berger F, Hacker C and Munz B. Strong induction of the Tis11B gene in myogenic differentiation. Eur J Cell Biol 87:31-38, 2008.
31. Cammas A, Sanchez BJ, Lian XJ, Dormoy-Raclet V, van der GK, de S, I, Ma J, Wilusz C, Richardson J, Gorospe M, Millevoi S, Giovarelli M, Gherzi R, Di MS and Gallouzi IE. Destabilization of nucleophosmin mRNA by the HuR/KSRP complex is required for muscle fibre formation. Nat Commun 5:4190, 2014.
32. Campana L, Santarella F, Esposito A, Maugeri N, Rigamonti E, Monno A, Canu T, Del MA, Bianchi ME, Manfredi AA and Rovere-Querini P. Leukocyte HMGB1 is required for vessel remodeling in regenerating muscles. J Immunol 192:5257-5264, 2014.
33. Cao H, Kelly MA, Kari F, Dawson HD, Urban JF, Jr., Coves S, Roussel AM and Anderson RA. Green tea increases antiinflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. J Inflamm (Lond) 4:1, 2007.
34. Carballo E, Lai WS and Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281:1001-1005, 1998.
35. Carballo E, Lai WS and Blackshear PJ. Evidence that tristetraprolin is a physiological regulator of granulocytemacrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95:1891-1899, 2000.
36. Carpenter S, Ricci EP, Mercier BC, Moore MJ and Fitzgerald KA. Post-transcriptional regulation of gene expression in innate immunity. Nat Rev Immunol 14:361-376, 2014.
37. Chakkalakal JV, Miura P, Belanger G, Michel RN and Jasmin BJ. Modulation of utrophin A mRNA stability in fast versus slow muscles via an AU-rich element and calcineurin signaling. Nucleic Acids Res 36:826-838, 2008.
38. Chen YW, Hubal MJ, Hoffman EP, Thompson PD and Clarkson PM. Molecular responses of human muscle to eccentric exercise. J Appl Physiol (1985) 95:2485-2494, 2003.
39. Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, Pouyssegur J, Lamarre J and Feige JJ. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene 23:8673-8680, 2004.
40. Ciais D, Cherradi N and Feige JJ. Multiple functions of tristetraprolin/TIS11 RNA-binding proteins in the regulation of mRNA biogenesis and degradation. Cell Mol Life Sci 70:2031-2044, 2013.
41. Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, Rakhilin SV, Stitt TN, Patterson C, Latres E and Glass DJ. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 6:376-385, 2007.
42. D'souza D, Lai RY, Shuen M and Hood DA. mRNA stability as a function of striated muscle oxidative capacity. Am J Physiol Regul Integr Comp Physiol 303:R408-R417, 2012.
43. Datta S, Biswas R, Novotny M, Pavicic PG, Jr., Herjan T, Mandal P and Hamilton TA. Tristetraprolin regulates CXCL1 (KC) mRNA stability. J Immunol 180:2545-2552, 2008.
44. Deng B, Wehling-Henricks M, Villalta SA, Wang Y and Tidball JG. IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J Immunol 189:3669-3680, 2012.
45. Deschenes-Furry J, Angus LM, Belanger G, Mwanjewe J and Jasmin BJ. Role of ELAV-like RNA-binding proteins HuD and HuR in the post-transcriptional regulation of acetylcholinesterase in neurons and skeletal muscle cells. Chem Biol Interact 157-158:43-49, 2005.
46. Deschenes-Furry J, Belanger G, Mwanjewe J, Lunde JA, Parks RJ, Perrone-Bizzozero N and Jasmin BJ. The RNAbinding protein HuR binds to acetylcholinesterase transcripts and regulates their expression in differentiating skeletal muscle cells. J Biol Chem 280:25361-25368, 2005.
47. Di MS, Mazroui R, Dallaire P, Chittur S, Tenenbaum SA, Radzioch D, Marette A and Gallouzi IE. NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release. Mol Cell Biol 25:6533-6545, 2005.
48. Dias P, Dilling M and Houghton P. The molecular basis of skeletal muscle differentiation. Semin Diagn Pathol 11:3-14, 1994.
49. Dormoy-Raclet V, Cammas A, Celona B, Lian XJ, van der GK, Zivojnovic M, Brunelli S, Riuzzi F, Sorci G, Wilhelm BT, Di MS, Donato R, Bianchi ME and Gallouzi IE. HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA. Nat Commun 4:2388, 2013.
50. Fan J, Ishmael FT, Fang X, Myers A, Cheadle C, Huang SK, Atasoy U, Gorospe M and Stellato C. Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium. J Immunol 186:2482-2494, 2011.
51. Figueroa A, Cuadrado A, Fan J, Atasoy U, Muscat GE, Munoz-Canoves P, Gorospe M and Munoz A. Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes. Mol Cell Biol 23:4991-5004, 2003.
52. Fink LN, Costford SR, Lee YS, Jensen TE, Bilan PJ, Oberbach A, Bluher M, Olefsky JM, Sams A and Klip A. Pro-Inflammatory macrophages increase in skeletal muscle of high fat-Fed mice and correlate with metabolic risk markers in humans. Obesity (Silver Spring) 22:747-757, 2014.
53. Frederick ED, Ramos SB and Blackshear PJ. A unique C-terminal repeat domain maintains the cytosolic localization of the placenta-specific tristetraprolin family member ZFP36L3. J Biol Chem 283:14792-14800, 2008.
54. Geyer BC, Ben AS, Barbash S, Kilbourne J, Mor TS and Soreq H. Nicotinic stimulation induces Tristetraprolin over-production and attenuates inflammation in muscle. Biochim Biophys Acta 1823:368-378, 2012.
55. Gramolini AO, Belanger G, Thompson JM, Chakkalakal JV and Jasmin BJ. Increased expression of utrophin in a slow vs. a fast muscle involves posttranscriptional events. Am J Physiol Cell Physiol 281:C1300-C1309, 2001.
56. Griffin CA, Apponi LH, Long KK and Pavlath GK. Chemokine expression and control of muscle cell migration during myogenesis. J Cell Sci 123:3052-3060, 2010.
57. Grounds MD and Torrisi J. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 18:676-682, 2004.
58. Gruber AR, Fallmann J, Kratochvill F, Kovarik P and Hofacker IL. AREsite: a database for the comprehensive investigation of AU-rich elements. Nucleic Acids Res 39:D66-D69, 2011.
59. Gu L, Ning H, Qian X, Huang Q, Hou R, Almourani R, Fu M, Blackshear PJ and Liu J. Suppression of IL-12 production by tristetraprolin through blocking NF-kcyB nuclear translocation. J Immunol 191:3922-3930, 2013.
60. Henningsen J, Pedersen BK and Kratchmarova I. Quantitative analysis of the secretion of the MCP family of chemokines by muscle cells. Mol Biosyst 7:311-321, 2011.
61. Herjan T, Yao P, Qian W, Li X, Liu C, Bulek K, Sun D, Yang WP, Zhu J, He A, Carman JA, Erzurum SC, Lipshitz HD, Fox PL, Hamilton TA and Li X. HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization. J Immunol 191:640-649, 2013.
62. Heusinkveld M, de Vos van Steenwijk PJ, Goedemans R, Ramwadhdoebe TH, Gorter A, Welters MJ, van HT and van der Burg SH. M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells. J Immunol 187:1157-1165, 2011.
63. Hodgetts S, Radley H, Davies M and Grounds MD. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice. Neuromuscul Disord 16:591-602, 2006.
64. Hoene M, Franken H, Fritsche L, Lehmann R, Pohl AK, Haring HU, Zell A, Schleicher ED and Weigert C. Activation of the mitogen-activated protein kinase (MAPK) signalling pathway in the liver of mice is related to plasma glucose levels after acute exercise. Diabetologia 53:1131-1141, 2010.
65. Hoene M, Runge H, Haring HU, Schleicher ED and Weigert C. Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway. Am J Physiol Cell Physiol 304:C128-C136, 2013.
66. Hoene M and Weigert C. The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev 9:20-29, 2008.
67. Hoppeler H, Baum O, Lurman G and Mueller M. Molecular mechanisms of muscle plasticity with exercise. Compr Physiol 1:1383-1412, 2011.
68. Hubal MJ, Chen TC, Thompson PD and Clarkson PM. Inflammatory gene changes associated with the repeated-bout effect. Am J Physiol Regul Integr Comp Physiol 294:R1628-R1637, 2008.
69. Jeffrey KL, Camps M, Rommel C and Mackay CR. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 6:391-403, 2007.
70. Jensen GL. Inflammation: roles in aging and sarcopenia. JPEN J Parenter Enteral Nutr 32:656-659, 2008.
71. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di PF, Lin SC, Gram H and Han J. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120:623-634, 2005.
72. Keller P, Penkowa M, Keller C, Steensberg A, Fischer CP, Giralt M, Hidalgo J and Pedersen BK. Interleukin-6 receptor expression in contracting human skeletal muscle: regulating role of IL-6. FASEB J 19:1181-1183, 2005.
73. Khabar KS. Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell Mol Life Sci 67:2937-2955, 2010.
74. Kharraz Y, Guerra J, Mann CJ, Serrano AL and Munoz-Canoves P. Macrophage plasticity and the role of inflammation in skeletal muscle repair. Mediators Inflamm 2013:491497, 2013.
75. Knight JD and Kothary R. The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis. Skelet Muscle 1:29, 2011.
76. Korotkova M and Lundberg IE. The skeletal muscle arachidonic acid cascade in health and inflammatory disease. Nat Rev Rheumatol 10:295-303, 2014.
77. Kuwano Y, Kim HH, Abdelmohsen K, Pullmann R, Jr., Martindale JL, Yang X and Gorospe M. MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol Cell Biol 28:4562-4575, 2008.
78. Lai RY, Ljubicic V, D'souza D and Hood DA. Effect of chronic contractile activity on mRNA stability in skeletal muscle. Am J Physiol Cell Physiol 299:C155-C163, 2010.
79. Lai WS and Blackshear PJ. Interactions of CCCH zinc finger proteins with mRNA: tristetraprolin-mediated AU-rich elementdependent mRNA degradation can occur in the absence of a poly (A) tail. J Biol Chem 276:23144-23154, 2001.
80. Lai WS, Carballo E, Thorn JM, Kennington EA and Blackshear PJ. Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA. J Biol Chem 275:17827-17837, 2000.
81. Lenk K, Schuler G and Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 1:9-21, 2010.
82. Liang J, Lei T, Song Y, Yanes N, Qi Y and Fu M. RNA-destabilizing factor tristetraprolin negatively regulates NF-kappaB signaling. J Biol Chem 284:29383-29390, 2009.
83. Lin NY, Lin CT and Chang CJ. Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 365:69-74, 2008.
84. Liu L, Ge D, Ma L, Mei J, Liu S, Zhang Q, Ren F, Liao H, Pu Q, Wang T and You Z. Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer. J Thorac Oncol 7:1091-1100, 2012.
85. Lu H, Huang D, Ransohoff RM and Zhou L. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J 25:3344-3355, 2011.
86. Marderosian M, Sharma A, Funk AP, Vartanian R, Masri J, Jo OD and Gera JF. Tristetraprolin regulates Cyclin D1 and c-yc mRNA stability in response to rapamycin in an Aktdependent manner via p38 MAPK signaling. Oncogene 25:6277-6290, 2006.
87. Marino M, Scuderi F, Provenzano C and Bartoccioni E. Skeletal muscle cells: from local inflammatory response to active immunity. Gene Ther 18:109-116, 2011.
88. Matravadia S, Martino VB, Sinclair D, Mutch DM and Holloway GP. Exercise training increases the expression and nuclear localization of mRNA destabilizing proteins in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 305:R822-R831, 2013.
89. Moncaut N, Rigby PW and Carvajal JJ. Dial M (RF) for myogenesis. FEBS J 280:3980-3990, 2013.
90. Munoz-Canoves P, Scheele C, Pedersen BK and Serrano AL. Interleukin-6 myokine signaling in skeletal muscle: a doubleedged sword? FEBS J 280:4131-4148, 2013.
91. Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K and Plotz P. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 113:407-414, 1998.
92. Narici MV and Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull 95:139-159, 2010.
93. Nathan C and Ding A. Nonresolving inflammation. Cell 140:871-882, 2010.
94. Nguyen HX, Lusis AJ and Tidball JG. Null mutation of myeloperoxidase in mice prevents mechanical activation of neutrophil lysis of muscle cell membranes in vitro and in vivo. J Physiol 565:403-413, 2005.
95. Nimmo MA, Leggate M, Viana JL and King JA. The effect of physical activity on mediators of inflammation. Diabetes Obes Metab 15 Suppl 3:51-60, 2013.
96. Onesti JK and Guttridge DC. Inflammation Based Regulation of Cancer Cachexia. Biomed Res Int 2014:168407, 2014.
97. Ortega-Gomez A, Perretti M and Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med 5:661-674, 2013.
98. Palanisamy V, Jakymiw A, Van Tubergen EA, D'Silva NJ and Kirkwood KL. Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J Dent Res 91:651-658, 2012.
99. Panda AC, Abdelmohsen K, Yoon JH, Martindale JL, Yang X, Curtis J, Mercken EM, Chenette DM, Zhang Y, Schneider RJ, Becker KG, de CR and Gorospe M. RNA-binding protein AUF1 promotes myogenesis by regulating MEF2C expression levels. Mol Cell Biol 2014.
100. Patino WD, Kang JG, Matoba S, Mian OY, Gochuico BR and Hwang PM. Atherosclerotic plaque macrophage transcriptional regulators are expressed in blood and modulated by tristetraprolin. Circ Res 98:1282-1289, 2006.
101. Peake J, Nosaka K and Suzuki K. Characterization of inflammatory responses to eccentric exercise in humans. Exerc Immunol Rev 11:64-85, 2005.
102. Pedersen BK and Fischer CP. Physiological roles of musclederived interleukin-6 in response to exercise. Curr Opin Clin Nutr Metab Care 10:265-271, 2007.
103. Pedersen L, Olsen CH, Pedersen BK and Hojman P. Musclederived expression of the chemokine CXCL1 attenuates dietinduced obesity and improves fatty acid oxidation in the muscle. Am J Physiol Endocrinol Metab 302:E831-E840, 2012.
104. Piccirillo CA, Bjur E, Topisirovic I, Sonenberg N and Larsson O. Translational control of immune responses: from transcripts to translatomes. Nat Immunol 15:503-511, 2014.
105. Pillon NJ, Arane K, Bilan PJ, Chiu TT and Klip A. Muscle cells challenged with saturated fatty acids mount an autonomous inflammatory response that activates macrophages. Cell Commun Signal 10:30, 2012.
106. Pillon NJ, Bilan PJ, Fink LN and Klip A. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab 304:E453-E465, 2013.
107. Poelkens F, Lammers G, Pardoel EM, Tack CJ and Hopman MT. Upregulation of skeletal muscle inflammatory genes links inflammation with insulin resistance in women with the metabolic syndrome. Exp Physiol 98:1485-1494, 2013.
108. Raschke S and Eckel J. Adipo-myokines: two sides of the same coin-mediators of inflammation and mediators of exercise. Mediators Inflamm 2013:320724, 2013.
109. Remels AH, Gosker HR, Langen RC and Schols AM. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol (1985) 114:1253-1262, 2013.
110. Rigamonti E, Touvier T, Clementi E, Manfredi AA, Brunelli S and Rovere-Querini P. Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage. J Immunol 190:1767-1777, 2013.
111. Rigamonti E, Zordan P, Sciorati C, Rovere-Querini P and Brunelli S. Macrophage plasticity in skeletal muscle repair. Biomed Res Int 2014:560629, 2014.
112. Riuzzi F, Sorci G, Sagheddu R and Donato R. HMGB1-RAGE regulates muscle satellite cell homeostasis through p38-. J Cell Sci 125:1440-1454, 2012.
113. Ruffell D, Mourkioti F, Gambardella A, Kirstetter P, Lopez RG, Rosenthal N and Nerlov C. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci U S A 106:17475-17480, 2009.
114. Sachidanandan C, Sambasivan R and Dhawan J. Tristetraprolin and LPS-inducible CXC chemokine are rapidly induced in presumptive satellite cells in response to skeletal muscle injury. J Cell Sci 115:2701-2712, 2002.
115. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH and Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412, 2004.
116. Sanduja S and Dixon DA. Tristetraprolin and E6-AP: Killing the messenger in cervical cancer. Cell Cycle 9:3135-3136, 2010.
117. Schakman O, Kalista S, Barbe C, Loumaye A and Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol 45:2163-2172, 2013.
118. Scheler M, Irmler M, Lehr S, Hartwig S, Staiger H, Al-Hasani H, Beckers J, de Angelis MH, Haring HU and Weigert C. Cytokine response of primary human myotubes in an in vitro exercise model. Am J Physiol Cell Physiol 305:C877-C886, 2013.
119. Schiaffino S and Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev 91:1447-1531, 2011.
120. Schichl YM, Resch U, Hofer-Warbinek R and de MR. Tristetraprolin impairs NF-kappaB/p65 nuclear translocation. J Biol Chem 284:29571-29581, 2009.
121. Schichl YM, Resch U, Lemberger CE, Stichlberger D and de MR. Novel phosphorylation-dependent ubiquitination of tristetraprolin by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1) and tumor necrosis factor receptor-associated factor 2 (TRAF2). J Biol Chem 286:38466-38477, 2011.
122. Schoenfeld BJ. The use of nonsteroidal anti-inflammatory drugs for exercise-induced muscle damage: implications for skeletal muscle development. Sports Med 42:1017-1028, 2012.
123. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG and Wallace JL. Resolution of inflammation: state of the art, definitions and terms. FASEB J 21:325-332, 2007.
124. Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M and Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 7:33-44, 2008.
125. Singh K and Dilworth FJ. Differential modulation of cell cycle progression distinguishes members of the myogenic regulatory factor family of transcription factors. FEBS J 280:3991-4003, 2013.
126. Spasic M, Friedel CC, Schott J, Kreth J, Leppek K, Hofmann S, Ozgur S and Stoecklin G. Genome-wide assessment of AUrich elements by the AREScore algorithm. PLoS Genet 8:e1002433, 2012.
127. Steensberg A, van HG, Osada T, Sacchetti M, Saltin B and Klarlund PB. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529 Pt 1:237-242, 2000.
128. Stoecklin G, Colombi M, Raineri I, Leuenberger S, Mallaun M, Schmidlin M, Gross B, Lu M, Kitamura T and Moroni C. Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. EMBO J 21:4709-4718, 2002.
129. Stoecklin G, Ming XF, Looser R and Moroni C. Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol Cell Biol 20:3753-3763, 2000.
130. Stoecklin G, Stoeckle P, Lu M, Muehlemann O and Moroni C. Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. RNA 7:1578-1588, 2001.
131. Stoecklin G, Tenenbaum SA, Mayo T, Chittur SV, George AD, Baroni TE, Blackshear PJ and Anderson P. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 283:11689-11699, 2008.
132. Strassmann G, Fong M, Windsor S and Neta R. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine 5:285-290, 1993.
133. Stumpo DJ, Broxmeyer HE, Ward T, Cooper S, Hangoc G, Chung YJ, Shelley WC, Richfield EK, Ray MK, Yoder MC, Aplan PD and Blackshear PJ. Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood 114:2401-2410, 2009.
134. Stumpo DJ, Byrd NA, Phillips RS, Ghosh S, Maronpot RR, Castranio T, Meyers EN, Mishina Y and Blackshear PJ. Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. Mol Cell Biol 24:6445-6455, 2004.
135. Tavi P and Westerblad H. The role of in vivo Ca (2) (+) signals acting on Ca (2) (+)-calmodulin-dependent proteins for skeletal muscle plasticity. J Physiol 589:5021-5031, 2011.
136. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF and Blackshear PJ. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4:445-454, 1996.
137. Tchen CR, Brook M, Saklatvala J and Clark AR. The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. J Biol Chem 279:32393-32400, 2004.
138. Tidball JG and Villalta SA. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 298:R1173-R1187, 2010.
139. Timchenko L. Molecular mechanisms of muscle atrophy in myotonic dystrophies. Int J Biochem Cell Biol 45:2280-2287, 2013.
140. Trappe TA and Liu SZ. Effects of prostaglandins and COXinhibiting drugs on skeletal muscle adaptations to exercise. J Appl Physiol (1985) 115:909-919, 2013.
141. Varnum BC, Lim RW, Sukhatme VP and Herschman HR. Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. Oncogene 4:119-120, 1989.
142. Vina J, Sanchis-Gomar F, Martinez-Bello V and Gomez-Cabrera MC. Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol 167:1-12, 2012.
143. von RC, Beauchamp P, Di MS and Gallouzi IE. HuR and myogenesis: being in the right place at the right time. Biochim Biophys Acta 1813:1663-1667, 2011.
144. Wagner PD. The critical role of VEGF in skeletal muscle angiogenesis and blood flow. Biochem Soc Trans 39:1556-1559, 2011.
145. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A and Simon P. Position statement. Part one: Immune function and exercise. Exerc Immunol Rev 17:6-63, 2011.
146. Wang YX and Rudnicki MA. Satellite cells, the engines of muscle repair. Nat Rev Mol Cell Biol 13:127-133, 2012.
147. Weigert C, Dufer M, Simon P, Debre E, Runge H, Brodbeck K, Haring HU and Schleicher ED. Upregulation of IL-6 mRNA by IL-6 in skeletal muscle cells: role of IL-6 mRNA stabilization and Ca2+-dependent mechanisms. Am J Physiol Cell Physiol 293:C1139-C1147, 2007.
148. White EJ, Brewer G and Wilson GM. Post-transcriptional control of gene expression by AUF1: mechanisms, physiological targets, and regulation. Biochim Biophys Acta 1829:680-688, 2013.
149. White JP, Puppa MJ, Sato S, Gao S, Price RL, Baynes JW, Kostek MC, Matesic LE and Carson JA. IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse. Skelet Muscle 2:14, 2012.
150. Yin H, Price F and Rudnicki MA. Satellite cells and the muscle stem cell niche. Physiol Rev 93:23-67, 2013.
151. Ylostalo JH, Bartosh TJ, Coble K and Prockop DJ. Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells 30:2283-2296, 2012.
152. Zanou N and Gailly P. Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways. Cell Mol Life Sci 70:4117-4130, 2013.
153. Zhang C, Li Y, Wu Y, Wang L, Wang X and Du J. Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. J Biol Chem 288:1489-1499, 2013.
154. Zhang J, Xiao Z, Qu C, Cui W, Wang X and Du J. CD8 T Cells Are Involved in Skeletal Muscle Regeneration through Facilitating MCP-1 Secretion and Gr1high Macrophage Infiltration. J Immunol 2014.
155. Zhang L, Lee JE, Wilusz J and Wilusz CJ. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. J Biol Chem 283:22457-22463, 2008.
156. Zhao W, Liu M, D'Silva NJ and Kirkwood KL. Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region. J Interferon Cytokine Res 31:629-637, 2011.
157. Zhao W, Liu M and Kirkwood KL. p38alpha stabilizes interleukin-6 mRNA via multiple AU-rich elements. J Biol Chem 283:1778-1785, 2008.
158. Zubiaga AM, Belasco JG and Greenberg ME. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15:2219-2230, 1995.